First-pass extracted concept

biomarkers

Candidate: concept label2 source documents2 linked claims

Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Evidence Snippets

This emerging understanding of Parkinson's syndrome, coupled with advances in biomarkers and targeted therapies, presages successful precision medicine strategies.

Evidence 1Source 1DOI PubMedprovenance

Improved understanding of the etiology of acute and chronic pain will enable the discovery of novel targets and regulatable pain circuits for safe and effective therapeutics, as well as relevant biomarkers to ensure adequate testing in clinical trials.

Evidence 2Source 2DOI PubMedprovenance

Supporting Sources

Source 1review2022Annual Review of Pathology Mechanisms of DiseaseDOI PubMed

1 evidence snippet 1 linked claim Claim 1

Source 2review2019Journal of Pharmacology and Experimental TherapeuticsDOI PubMed

1 evidence snippet 1 linked claim Claim 1

Linked Claims

Claim 1translational outlooksupports2022Source 1DOI PubMed

Advances in mechanistic understanding, biomarkers, and targeted therapies suggest that precision medicine strategies for Parkinson's syndrome may become successful.

Claim 2review summarysupports2019Source 2DOI PubMed

Improved understanding of acute and chronic pain etiology can enable discovery of novel targets, regulatable pain circuits, and relevant biomarkers for safer and more effective therapeutics and clinical-trial testing.